vs
BALCHEM CORP（BCPC）与PROCORE TECHNOLOGIES, INC.（PCOR）财务数据对比。点击上方公司名可切换其他公司
PROCORE TECHNOLOGIES, INC.的季度营收约是BALCHEM CORP的1.3倍（$349.1M vs $263.6M），BALCHEM CORP净利率更高（14.9% vs -10.8%，领先25.7%），PROCORE TECHNOLOGIES, INC.同比增速更快（15.6% vs 9.8%），过去两年PROCORE TECHNOLOGIES, INC.的营收复合增速更高（13.8% vs 4.9%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
Procore Technologies是2002年成立的美国建筑管理软件即服务（SaaS）企业，总部位于加利福尼亚州卡平特里亚。公司打造的全球平台可连接建筑行业从业者，支持搭建简化工作流，统一展现建筑项目信息，覆盖任务追踪、项目流程管理、日程排期等核心功能。
BCPC vs PCOR — 直观对比
营收规模更大
PCOR
是对方的1.3倍
$263.6M
营收增速更快
PCOR
高出5.7%
9.8%
净利率更高
BCPC
高出25.7%
-10.8%
两年增速更快
PCOR
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $349.1M |
| 净利润 | $39.2M | $-37.6M |
| 毛利率 | 35.6% | 80.1% |
| 营业利润率 | 19.8% | -12.3% |
| 净利率 | 14.9% | -10.8% |
| 营收同比 | 9.8% | 15.6% |
| 净利润同比 | 16.8% | 39.6% |
| 每股收益（稀释后） | $1.21 | $-0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCPCOR
| Q4 25 | $263.6M | $349.1M | ||
| Q3 25 | $267.6M | $338.9M | ||
| Q2 25 | $255.5M | $323.9M | ||
| Q1 25 | $250.5M | $310.6M | ||
| Q4 24 | $240.0M | $302.0M | ||
| Q3 24 | $239.9M | $295.9M | ||
| Q2 24 | $234.1M | $284.3M | ||
| Q1 24 | $239.7M | $269.4M |
净利润BCPCPCOR
| Q4 25 | $39.2M | $-37.6M | ||
| Q3 25 | $40.3M | $-9.1M | ||
| Q2 25 | $38.3M | $-21.1M | ||
| Q1 25 | $37.1M | $-33.0M | ||
| Q4 24 | $33.6M | $-62.3M | ||
| Q3 24 | $33.8M | $-26.4M | ||
| Q2 24 | $32.1M | $-6.3M | ||
| Q1 24 | $29.0M | $-11.0M |
毛利率BCPCPCOR
| Q4 25 | 35.6% | 80.1% | ||
| Q3 25 | 35.7% | 79.7% | ||
| Q2 25 | 36.4% | 79.1% | ||
| Q1 25 | 35.2% | 79.1% | ||
| Q4 24 | 36.0% | 81.2% | ||
| Q3 24 | 35.6% | 81.4% | ||
| Q2 24 | 35.5% | 83.1% | ||
| Q1 24 | 34.0% | 83.0% |
营业利润率BCPCPCOR
| Q4 25 | 19.8% | -12.3% | ||
| Q3 25 | 20.4% | -4.4% | ||
| Q2 25 | 20.1% | -9.3% | ||
| Q1 25 | 20.4% | -11.7% | ||
| Q4 24 | 19.8% | -21.9% | ||
| Q3 24 | 20.0% | -12.3% | ||
| Q2 24 | 19.6% | -5.2% | ||
| Q1 24 | 17.4% | -7.0% |
净利率BCPCPCOR
| Q4 25 | 14.9% | -10.8% | ||
| Q3 25 | 15.1% | -2.7% | ||
| Q2 25 | 15.0% | -6.5% | ||
| Q1 25 | 14.8% | -10.6% | ||
| Q4 24 | 14.0% | -20.6% | ||
| Q3 24 | 14.1% | -8.9% | ||
| Q2 24 | 13.7% | -2.2% | ||
| Q1 24 | 12.1% | -4.1% |
每股收益（稀释后）BCPCPCOR
| Q4 25 | $1.21 | $-0.25 | ||
| Q3 25 | $1.24 | $-0.06 | ||
| Q2 25 | $1.17 | $-0.14 | ||
| Q1 25 | $1.13 | $-0.22 | ||
| Q4 24 | $1.03 | $-0.42 | ||
| Q3 24 | $1.03 | $-0.18 | ||
| Q2 24 | $0.98 | $-0.04 | ||
| Q1 24 | $0.89 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $768.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $1.3B |
| 总资产 | $1.7B | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCPCPCOR
| Q4 25 | $74.6M | $768.5M | ||
| Q3 25 | $65.1M | $684.0M | ||
| Q2 25 | $65.4M | $620.9M | ||
| Q1 25 | $49.9M | $566.7M | ||
| Q4 24 | $49.5M | $775.4M | ||
| Q3 24 | $73.7M | $756.9M | ||
| Q2 24 | $63.7M | $735.4M | ||
| Q1 24 | $60.3M | $744.6M |
股东权益BCPCPCOR
| Q4 25 | $1.3B | $1.3B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.2B | $1.2B | ||
| Q4 24 | $1.1B | $1.3B | ||
| Q3 24 | $1.2B | $1.3B | ||
| Q2 24 | $1.1B | $1.3B | ||
| Q1 24 | $1.1B | $1.2B |
总资产BCPCPCOR
| Q4 25 | $1.7B | $2.2B | ||
| Q3 25 | $1.7B | $2.1B | ||
| Q2 25 | $1.7B | $2.0B | ||
| Q1 25 | $1.6B | $1.9B | ||
| Q4 24 | $1.6B | $2.1B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.6B | $2.0B | ||
| Q1 24 | $1.6B | $1.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $114.9M |
| 自由现金流经营现金流 - 资本支出 | — | $109.2M |
| 自由现金流率自由现金流/营收 | — | 31.3% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | $282.2M |
8季度趋势，按日历期对齐
经营现金流BCPCPCOR
| Q4 25 | $67.3M | $114.9M | ||
| Q3 25 | $65.6M | $88.5M | ||
| Q2 25 | $47.3M | $30.8M | ||
| Q1 25 | $36.5M | $66.0M | ||
| Q4 24 | $52.3M | $29.1M | ||
| Q3 24 | $51.3M | $39.3M | ||
| Q2 24 | $45.0M | $58.7M | ||
| Q1 24 | $33.4M | $69.1M |
自由现金流BCPCPCOR
| Q4 25 | — | $109.2M | ||
| Q3 25 | — | $83.1M | ||
| Q2 25 | — | $27.9M | ||
| Q1 25 | — | $62.0M | ||
| Q4 24 | — | $17.4M | ||
| Q3 24 | — | $35.7M | ||
| Q2 24 | — | $56.8M | ||
| Q1 24 | — | $67.1M |
自由现金流率BCPCPCOR
| Q4 25 | — | 31.3% | ||
| Q3 25 | — | 24.5% | ||
| Q2 25 | — | 8.6% | ||
| Q1 25 | — | 20.0% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | — | 12.1% | ||
| Q2 24 | — | 20.0% | ||
| Q1 24 | — | 24.9% |
资本支出强度BCPCPCOR
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 0.8% |
现金转化率BCPCPCOR
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
PCOR
| US | $298.3M | 85% |
| Non Us | $50.9M | 15% |
